CELGENE THALIDOMIDE owner Contact Information online
from Celgene Corporation
CELGENE THALIDOMIDE
The mark consists of a swirl design enclosed in a square with the words "CELGENE THALIDOMIDE".
US serial number:85067820
Application filling date:Jun. 21, 2010
Register:Principal
Mark type:Trademark
Status:Registered. The registration date is used to determine when post-registration maintenance documents are due.
Status date:Aug. 23, 2011
Publication date:Jun. 07, 2011
Standard character claim:No
Mark drawing type:3 - AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/ LETTER(S)/NUMBER(S)
Foreign foreign registration number:009191974
Foreign foreign registration date:Jan. 27, 2011
Foreign foreign application registration country:EUROPEAN (EU) OFFICE FOR HARMONIZATION IN THE INTERNAL MARKET (OHIM)
Foreign foreign expiration date:Jun. 21, 2020
Goods and services:For: Pharmaceutical preparations, namely, cytokine inhibitory drugs that contain thalidomide; pharmaceutical preparations used to treat cancers and immune related diseases that contain thalidomide
International Class(es): 005- Primary Class
U.S Class(es):
Services:Pharmaceutical preparations
namely
cytokine inhibitory drugs that contain thalidomide; pharmaceutical preparations used to treat cancers and immune related diseases that contain thalidomide
Current owner owner name:Celgene Corporation
Current owner owner address:86 Morris Avenue
Summit,
NEW JERSEY
UNITED STATES
07901
Current owner legal entity type:CORPORATION
Current owner state or country:DELAWARE
Attorney name:Camille M. Miller
Attorney email:cmiller@cozen.com
Attorney docket number:272545/CELG-
Attorney email authorized:No
Correspondent name address:CAMILLE M. MILLER
COZEN O'CONNOR, PC
1650 MARKET ST
One Liberty Place
PHILADELPHIA,
PENNSYLVANIA
UNITED STATES
19103-3508
Correspondent phone:215-665-7273
Correspondent email:cmiller@cozen.com
Correspondent fax:215-701-2273
Correspondent email authorized CELGENE THALIDOMIDE:Yes
Latest trademarks
Popular owners
Glaxo Group Limited (173) Novartis AG (132) JOHNSON & JOHNSON (126) Millennium Pharmaceuticals, Inc. (54) Eli Lilly and Company (51) Windmill Health Products, LLC (46) Bayer Aktiengesellschaft (44) SANOFI (41) Wyeth LLC (41) Pfizer Inc. (39) Forest Laboratories, Inc. (34) Bristol-Myers Squibb Company (33) Vital Health Pharmaceuticals, Inc. (31) Primary Investments Group Limited (28) S. C. Johnson & Son, Inc. (28) MERCK SHARP & DOHME CORP. (27) Futurebiotics, LLC (26) MONSTER ENERGY COMPANY (19) Scott Riddell (17) Ares Trading S.A. (16)Popular publication dates
Jun. 07, 2011 Mar. 08, 2011 Mar. 15, 2011 Mar. 22, 2011 Mar. 29, 2011 Nov. 16, 2010 Apr. 12, 2011 Apr. 19, 2011 Oct. 19, 2010 Oct. 26, 2010 Apr. 26, 2011 Feb. 15, 2011 Oct. 05, 2010 Oct. 12, 2010 Jan. 25, 2011 Sep. 21, 2010 Jan. 11, 2011 Feb. 22, 2011 Nov. 23, 2010 Sep. 28, 2010Similar brands
